-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Pacific Biosciences Of California, Inc. quarterly/annual Cost of Revenue history and growth rate from 2011 to 2023.
- Pacific Biosciences Of California, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $30.1M, a 6.1% decline year-over-year.
- Pacific Biosciences Of California, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $144M, a 41.2% increase year-over-year.
- Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2023 was $148M, a 86.4% increase from 2022.
- Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2022 was $79.3M, a 10.6% increase from 2021.
- Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2021 was $71.7M, a 54.7% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)